CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 4 Open-market buy Director bought 5,000 shares at $0.90 ($4,500)
- 4 Open-market buy Director bought 10,000 shares at $0.91 ($9,100)
- 4 Open-market buy Director bought 10,000 shares at $0.85 ($8,500)
- 4 Open-market buy Director bought 10,000 shares at $0.82 ($8,200)
- 4 Open-market buy Director bought 10,000 shares at $0.78 ($7,800)
- 4 Open-market buy Director bought 10,000 shares at $0.71 ($7,100)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · New debt or obligation · Delisting notice
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Grant or award Director acquired 41,587 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 42,857 shares (grant or award)
- 4 Grant or award Director acquired 42,857 shares (grant or award)
- 4 Grant or award Director acquired 42,857 shares (grant or award)
- 4 Grant or award Director acquired 42,857 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 86,580 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 79,653 shares (grant or award)
Page 17 of 28 · 547 filings